Dual Antiplatelet Therapy in Coronary Artery Disease

Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. While prasugrel demonstrated benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Raghav, Kumar, Prathap, Prashanth, S. P., Belagali, Yogesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584687/
https://www.ncbi.nlm.nih.gov/pubmed/32804330
http://dx.doi.org/10.1007/s40119-020-00197-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584687/
https://www.ncbi.nlm.nih.gov/pubmed/32804330
http://dx.doi.org/10.1007/s40119-020-00197-0

Ejemplares similares